Market Overview


  • Arzerra, Biotech, cancer, Darzalex, GMXAY, News

    Genmab IPO: What You Need To Know

    Monday, July 15, 2019 - 12:36pm

    An OTC-listed large-cap biotech is seeking a main exchange listing, and it offers scope for investing in a proven biotech with two commercial partnered products on the market and more in the pipeline. The IPO Terms Copenhagen, Denmark-based GENMAB A/S/S ADR (OTC: GMXAY) has filed for offering 27.80...